|
|
|
|
|
|
|
07.01.26 - 00:00
|
Ventyx Biosciences und BioAge Labs: Tenbagger-Rendite im No Brainer Club! (Sharedeals)
|
|
|
Mit Ventyx Biosciences feiert der No Brainer Club eine waschechte Tenbagger-Empfehlung: Nach Übernahmegerüchten springt die Aktie heute im regulären Handel zunächst um rund 30% nach oben, bevor sie nachbörslich noch einmal fast 60% drauflegt. Seit der ersten NBC-Empfehlung vor gut einem Jahr stehen damit über +1.000% Kursgewinn zu Buche. Ventyx vor Milliardenübernahme Nach einem Bericht […]
The post Ventyx Biosciences und BioAge Labs: Tenbagger-Rendite im No Brainer Club! first appeared on sharedeals.de....
|
|
|
23.12.25 - 21:27
|
Goldman′s Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors (ZeroHedge)
|
|
|
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors
There are just nine days left in the year, and this year has flown by.
We've delivered readers a steady stream of 2026 outlooks over the past few days and weeks, and next up is a year-ahead catalyst list from Goldman Sachs' small-cap biotech stock coverage.
Goldman analysts, led by Corinne Johnson, held their third "Year-Ahead" Catalyst Clinic, highlighting significant clinical catalysts for small-cap biotech companies (market caps under $3 billion) in their stock coverage universe.
Featured companies in the Catalyst Clinic included AbCellera Biologics, Allogene Therapeutics, Apogee Therapeutics, BioAge Labs, Entrada Therapeutics, Gossamer Bio, Gubra, Lyell Immunopharma, Recursion Pharmaceuticals, Sana Biotechnology, Sionna Therapeutics, Sera Prognostics, Tyra Biosciences, Viralgen, and Viridian Therapeutics.
Johnson said the sentiment from the event was mostly positive, with several names showing cl...
|
|
|
|
|
|
|
|
|
05.12.25 - 11:15
|
Fractyl Health und BioAge Labs: Weitere Top-Renditen im NBC! (Sharedeals)
|
|
|
Mit Fractyl Health und BioAge Labs blicken Mitglieder des No Brainer Club auf die nächsten großen Renditebringer in ihren Depots. Beide Empfehlungen konnten sich in den letzten Monaten im Wert verdoppeln. Fractyl Health schießt 74% über Kauflimit hinaus Die Aktie von Fractyl Health hatte NBC-Chefanalyst Maximilian Ruth im September mit einem Kauflimit von 1,18 US$ […]
The post Fractyl Health und BioAge Labs: Weitere Top-Renditen im NBC! first appeared on sharedeals.de....
|
|
|
25.11.25 - 22:33
|
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire EN)
|
|
|
EMERYVILLE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Piper Sandler 37th Annual Healthcare Conference taking place in New York, NY on December 2-4, 2025....
|
|
|
07.11.25 - 15:03
|
BioAge Labs to Present at Jefferies Global Healthcare Conference in London (GlobeNewswire EN)
|
|
|
EMERYVILLE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Jefferies Global Healthcare Conference in London, November 17–20, 2025....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.08.25 - 22:33
|
BioAge Labs to Present at Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
